Work

Comprehensive identification of FGFR1-4 alterations in 5 557 Chinese patients with solid tumors by next-generation sequencing.

Year: 2021

Type: article

Abstract: fusions may benefit from anlotinib.

Source: PubMed Central

Authors: Weiquan Gu, Jie Yang, Yong Wang, Jun Xu, Xiaoxuan Wang, Furong Du, Xiangjing Hu, Hao Guo, Chao Song, Rongjie Tao, Xuchao Zhang

Institutions: First People's Hospital of Foshan, Shandong University, Shandong Tumor Hospital, Shandong First Medical University, Simcere Pharmaceutical (China), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital

Language: English

Topic: Fibroblast Growth Factor Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3200211812

FWCI: 2.663

Cites: 41

Cited by: 45

Related to: 10